Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Definitive Healthcare (DH) Other financing activities (2021 - 2025)

Definitive Healthcare (DH) has disclosed Other financing activities for 5 consecutive years, with -$1.7 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Other financing activities changed N/A year-over-year to -$1.7 million, compared with a TTM value of $823000.0 through Dec 2025, down 87.85%, and an annual FY2023 reading of $4.4 million, up 155.59% over the prior year.
  • Other financing activities was -$1.7 million for Q4 2025 at Definitive Healthcare, down from $609000.0 in the prior quarter.
  • Across five years, Other financing activities topped out at $5.8 million in Q1 2024 and bottomed at -$1.7 million in Q4 2025.
  • Average Other financing activities over 5 years is $1.6 million, with a median of $1.3 million recorded in 2021.
  • The sharpest move saw Other financing activities surged 930.95% in 2022, then tumbled 67.72% in 2025.
  • Year by year, Other financing activities stood at $2.1 million in 2021, then tumbled by 79.45% to $435000.0 in 2022, then soared by 911.95% to $4.4 million in 2023, then plummeted by 77.99% to $969000.0 in 2024, then plummeted by 271.31% to -$1.7 million in 2025.
  • Business Quant data shows Other financing activities for DH at -$1.7 million in Q4 2025, $609000.0 in Q2 2025, and $1.9 million in Q1 2025.